Quantitative Determination of Combination of Amlodipine Besylate and Telmisartan in Tablets Using 1H-qNMR and Its Comparison to HPLC for Further Validation

HPLC and LC–MS are traditional drug-analysis methods, while 1 H-qNMR is increasingly popular as it is a non-destructive technique which does not require standards and enables efficient analysis of complex mixtures. This study used 1 H-qNMR for the quantitative determination of amlodipine besylate and telmisartan in tablets, and HPLC was employed for comparison. The 1 H-qNMR and HPLC methods showed strong linearity over concentration ranges of 1.0–5.00 mg/mL and 0.005–0.1 mg/mL, respectively, with regression coefficients (R²) greater than 0.99, indicating excellent linearity. In addition, the limit of detection and limit of quantification values determined using 1 H-qNMR were 0.328 and 1.09 mg/mL for amlodipine besylate and 0.277 and 0.923 mg/mL for telmisartan. The HPLC method yielded LOD and LOQ values of 0.0836 and 0.2533 µg/mL for amlodipine besylate and 0.0434 and 0.1446 µg/mL for telmisartan, respectively. Standard deviations and % RSD deviations for recovery tests of all samples were found to be within 0.41-1.54 and 0.005-1.55%, respectively. The results of the recovery test demonstrated that the signals at δ H 2.63 (H-39) and δ H 5.63 (H-16) ppm of telmisartan and δ H 2.31 (H-22) and δ H 5.31 (H-4) ppm of amlodipine besylate showed a more reliable recovery percentage with considerable standard deviation and RSD %. A 1 H-qNMR method was developed to determine the content of amlodipine besylate and telmisartan in tablets and validated using HPLC analysis. It enables the simultaneous quantification of both drugs in fixed-dose combination tablets, supporting accurate dosage control and effective therapeutic management. Quantitative Determination of Amlodipine Besylate and Telmisartan Combination in Tablets Using qNMR and HPLC • Reliable 1 H-qNMR method was developed for quantitative analysis of combination of Amlodipine Besylate and Telmisartan in tablets • The method paves the way for numerous future applications capability of analyzing multi-component mixtures

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Analysis
Published
2026-03-01
DOI
https://doi.org/10.1016/j.cpan.2026.03.010
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantitative Determination of Combination of Amlodipine Besylate and Telmisartan in Tablets Using 1H-qNMR and Its Comparison to HPLC for Further Validation

Siddha Raj Upadhyaya, Bishal Dahal, Shailendra Shakya, Ganga Ram Upadhayay et al.
Current Pharmaceutical Analysis
Analytical Methods in Pharmaceuticals
article

Quantitative Determination of Combination of Amlodipine Besylate and Telmisartan in Tablets Using 1H-qNMR and Its Comparison to HPLC for Further Validation

Siddha Raj Upadhyaya, Bishal Dahal, Shailendra Shakya, Ganga Ram Upadhayay, Bimala Lama, Sajan Lal Shyaula, Khem Raj Joshi
article en

Abstract

HPLC and LC–MS are traditional drug-analysis methods, while 1 H-qNMR is increasingly popular as it is a non-destructive technique which does not require standards and enables efficient analysis of complex mixtures. This study used 1 H-qNMR for the quantitative determination of amlodipine besylate and telmisartan in tablets, and HPLC was employed for comparison. The 1 H-qNMR and HPLC methods showed strong linearity over concentration ranges of 1.0–5.00 mg/mL and 0.005–0.1 mg/mL, respectively, with regression coefficients (R²) greater than 0.99, indicating excellent linearity. In addition, the limit of detection and limit of quantification values determined using 1 H-qNMR were 0.328 and 1.09 mg/mL for amlodipine besylate and 0.277 and 0.923 mg/mL for telmisartan. The HPLC method yielded LOD and LOQ values of 0.0836 and 0.2533 µg/mL for amlodipine besylate and 0.0434 and 0.1446 µg/mL for telmisartan, respectively. Standard deviations and % RSD deviations for recovery tests of all samples were found to be within 0.41-1.54 and 0.005-1.55%, respectively. The results of the recovery test demonstrated that the signals at δ H 2.63 (H-39) and δ H 5.63 (H-16) ppm of telmisartan and δ H 2.31 (H-22) and δ H 5.31 (H-4) ppm of amlodipine besylate showed a more reliable recovery percentage with considerable standard deviation and RSD %. A 1 H-qNMR method was developed to determine the content of amlodipine besylate and telmisartan in tablets and validated using HPLC analysis. It enables the simultaneous quantification of both drugs in fixed-dose combination tablets, supporting accurate dosage control and effective therapeutic management. Quantitative Determination of Amlodipine Besylate and Telmisartan Combination in Tablets Using qNMR and HPLC • Reliable 1 H-qNMR method was developed for quantitative analysis of combination of Amlodipine Besylate and Telmisartan in tablets • The method paves the way for numerous future applications capability of analyzing multi-component mixtures

Current Pharmaceutical Analysis
Pokhara University (NP), University of Colorado Boulder (US), Kathmandu University (NP), Nepal Academy of Science and Technology (NP)
Zero hunger
Openalex Percentile: Top 7%
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.